Anterior cruciate ligament reconstruction with a novel porcine xenograft: The initial Italian experience

Stefano Zaffagnini, Alberto Grassi, Giulio Maria Marcheggiani Muccioli, Tommaso Roberti Di Sarsina, Federico Raggi, Andrea Benzi, Maurilio Marcacci

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

At the current state of the art in anterior cruciate ligament (ACL) reconstruction, multiple techniques have been presented but none has given clearly defined and improved results. One of the main issues concerns the choice of graft. The concept of using xenograft tissue, defined as a graft tissue from one species and destined for implantation in an unlike species, was introduced in order to try to overcome the mechanical and biological concerns associated with synthetic materials and the safety and quality concerns and availability problems of allograft tissue. Xenograft tissue carries the risk of producing an immunological reaction. In order to try to overcome or attenuate the immune response against porcine xenograft tissue, the Z-Process® (Aperion Biologics Inc, San Antonio, Texas, USA) has been developed and used to produce the Z-Lig® family of devices for ACL reconstruction procedures. Z-Lig® is a tendon graft with or without bone blocks, sourced from animal tissue in a manner consistent with what has normally been sourced from human tissue, and processed to overcome anti-Gal-mediated rejection and to attenuate other immunological recognition in humans. All this while ensuring sterility, viral inactivation and preservation of mechanical proprieties appropriate for an ACL reconstruction device. The Z-Lig® device has been tested in skeletally mature monkeys and given interesting and promising results from the preclinical performance and safety profile point of view. On this basis, it was possible to proceed with the first clinical trial involving humans, which gave similar encouraging results. The Z-Lig® device has also been implanted in Italy at the Rizzoli Orthopaedic Institute in Bologna, as a part of international multicenter prospective randomized blinded controlled study aimed at comparing xenograft with allograft tissue.

Original languageEnglish
Pages (from-to)85-90
Number of pages6
JournalJoints
Volume3
Issue number2
DOIs
Publication statusPublished - Apr 1 2015

Fingerprint

Anterior Cruciate Ligament Reconstruction
Heterografts
Swine
Equipment and Supplies
Transplants
Allografts
Virus Inactivation
Introduced Species
Safety
Biological Products
Tendons
Infertility
Italy
Haplorhini
Orthopedics
Clinical Trials
Bone and Bones

Keywords

  • Anterior cruciate ligament
  • Knee
  • Reconstruction
  • Xenograft
  • Z-Lig

ASJC Scopus subject areas

  • Orthopedics and Sports Medicine
  • Rehabilitation
  • Surgery

Cite this

Zaffagnini, S., Grassi, A., Muccioli, G. M. M., Di Sarsina, T. R., Raggi, F., Benzi, A., & Marcacci, M. (2015). Anterior cruciate ligament reconstruction with a novel porcine xenograft: The initial Italian experience. Joints, 3(2), 85-90. https://doi.org/10.11138/jts/2015.3.2.085

Anterior cruciate ligament reconstruction with a novel porcine xenograft : The initial Italian experience. / Zaffagnini, Stefano; Grassi, Alberto; Muccioli, Giulio Maria Marcheggiani; Di Sarsina, Tommaso Roberti; Raggi, Federico; Benzi, Andrea; Marcacci, Maurilio.

In: Joints, Vol. 3, No. 2, 01.04.2015, p. 85-90.

Research output: Contribution to journalArticle

Zaffagnini, S, Grassi, A, Muccioli, GMM, Di Sarsina, TR, Raggi, F, Benzi, A & Marcacci, M 2015, 'Anterior cruciate ligament reconstruction with a novel porcine xenograft: The initial Italian experience', Joints, vol. 3, no. 2, pp. 85-90. https://doi.org/10.11138/jts/2015.3.2.085
Zaffagnini, Stefano ; Grassi, Alberto ; Muccioli, Giulio Maria Marcheggiani ; Di Sarsina, Tommaso Roberti ; Raggi, Federico ; Benzi, Andrea ; Marcacci, Maurilio. / Anterior cruciate ligament reconstruction with a novel porcine xenograft : The initial Italian experience. In: Joints. 2015 ; Vol. 3, No. 2. pp. 85-90.
@article{af54ad881b6b4256ada99c72e01a1315,
title = "Anterior cruciate ligament reconstruction with a novel porcine xenograft: The initial Italian experience",
abstract = "At the current state of the art in anterior cruciate ligament (ACL) reconstruction, multiple techniques have been presented but none has given clearly defined and improved results. One of the main issues concerns the choice of graft. The concept of using xenograft tissue, defined as a graft tissue from one species and destined for implantation in an unlike species, was introduced in order to try to overcome the mechanical and biological concerns associated with synthetic materials and the safety and quality concerns and availability problems of allograft tissue. Xenograft tissue carries the risk of producing an immunological reaction. In order to try to overcome or attenuate the immune response against porcine xenograft tissue, the Z-Process{\circledR} (Aperion Biologics Inc, San Antonio, Texas, USA) has been developed and used to produce the Z-Lig{\circledR} family of devices for ACL reconstruction procedures. Z-Lig{\circledR} is a tendon graft with or without bone blocks, sourced from animal tissue in a manner consistent with what has normally been sourced from human tissue, and processed to overcome anti-Gal-mediated rejection and to attenuate other immunological recognition in humans. All this while ensuring sterility, viral inactivation and preservation of mechanical proprieties appropriate for an ACL reconstruction device. The Z-Lig{\circledR} device has been tested in skeletally mature monkeys and given interesting and promising results from the preclinical performance and safety profile point of view. On this basis, it was possible to proceed with the first clinical trial involving humans, which gave similar encouraging results. The Z-Lig{\circledR} device has also been implanted in Italy at the Rizzoli Orthopaedic Institute in Bologna, as a part of international multicenter prospective randomized blinded controlled study aimed at comparing xenograft with allograft tissue.",
keywords = "Anterior cruciate ligament, Knee, Reconstruction, Xenograft, Z-Lig",
author = "Stefano Zaffagnini and Alberto Grassi and Muccioli, {Giulio Maria Marcheggiani} and {Di Sarsina}, {Tommaso Roberti} and Federico Raggi and Andrea Benzi and Maurilio Marcacci",
year = "2015",
month = "4",
day = "1",
doi = "10.11138/jts/2015.3.2.085",
language = "English",
volume = "3",
pages = "85--90",
journal = "Joints",
issn = "2282-4324",
publisher = "CIC Edizioni Internazionali s.r.l.",
number = "2",

}

TY - JOUR

T1 - Anterior cruciate ligament reconstruction with a novel porcine xenograft

T2 - The initial Italian experience

AU - Zaffagnini, Stefano

AU - Grassi, Alberto

AU - Muccioli, Giulio Maria Marcheggiani

AU - Di Sarsina, Tommaso Roberti

AU - Raggi, Federico

AU - Benzi, Andrea

AU - Marcacci, Maurilio

PY - 2015/4/1

Y1 - 2015/4/1

N2 - At the current state of the art in anterior cruciate ligament (ACL) reconstruction, multiple techniques have been presented but none has given clearly defined and improved results. One of the main issues concerns the choice of graft. The concept of using xenograft tissue, defined as a graft tissue from one species and destined for implantation in an unlike species, was introduced in order to try to overcome the mechanical and biological concerns associated with synthetic materials and the safety and quality concerns and availability problems of allograft tissue. Xenograft tissue carries the risk of producing an immunological reaction. In order to try to overcome or attenuate the immune response against porcine xenograft tissue, the Z-Process® (Aperion Biologics Inc, San Antonio, Texas, USA) has been developed and used to produce the Z-Lig® family of devices for ACL reconstruction procedures. Z-Lig® is a tendon graft with or without bone blocks, sourced from animal tissue in a manner consistent with what has normally been sourced from human tissue, and processed to overcome anti-Gal-mediated rejection and to attenuate other immunological recognition in humans. All this while ensuring sterility, viral inactivation and preservation of mechanical proprieties appropriate for an ACL reconstruction device. The Z-Lig® device has been tested in skeletally mature monkeys and given interesting and promising results from the preclinical performance and safety profile point of view. On this basis, it was possible to proceed with the first clinical trial involving humans, which gave similar encouraging results. The Z-Lig® device has also been implanted in Italy at the Rizzoli Orthopaedic Institute in Bologna, as a part of international multicenter prospective randomized blinded controlled study aimed at comparing xenograft with allograft tissue.

AB - At the current state of the art in anterior cruciate ligament (ACL) reconstruction, multiple techniques have been presented but none has given clearly defined and improved results. One of the main issues concerns the choice of graft. The concept of using xenograft tissue, defined as a graft tissue from one species and destined for implantation in an unlike species, was introduced in order to try to overcome the mechanical and biological concerns associated with synthetic materials and the safety and quality concerns and availability problems of allograft tissue. Xenograft tissue carries the risk of producing an immunological reaction. In order to try to overcome or attenuate the immune response against porcine xenograft tissue, the Z-Process® (Aperion Biologics Inc, San Antonio, Texas, USA) has been developed and used to produce the Z-Lig® family of devices for ACL reconstruction procedures. Z-Lig® is a tendon graft with or without bone blocks, sourced from animal tissue in a manner consistent with what has normally been sourced from human tissue, and processed to overcome anti-Gal-mediated rejection and to attenuate other immunological recognition in humans. All this while ensuring sterility, viral inactivation and preservation of mechanical proprieties appropriate for an ACL reconstruction device. The Z-Lig® device has been tested in skeletally mature monkeys and given interesting and promising results from the preclinical performance and safety profile point of view. On this basis, it was possible to proceed with the first clinical trial involving humans, which gave similar encouraging results. The Z-Lig® device has also been implanted in Italy at the Rizzoli Orthopaedic Institute in Bologna, as a part of international multicenter prospective randomized blinded controlled study aimed at comparing xenograft with allograft tissue.

KW - Anterior cruciate ligament

KW - Knee

KW - Reconstruction

KW - Xenograft

KW - Z-Lig

UR - http://www.scopus.com/inward/record.url?scp=84979082311&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84979082311&partnerID=8YFLogxK

U2 - 10.11138/jts/2015.3.2.085

DO - 10.11138/jts/2015.3.2.085

M3 - Article

AN - SCOPUS:84979082311

VL - 3

SP - 85

EP - 90

JO - Joints

JF - Joints

SN - 2282-4324

IS - 2

ER -